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AbstrAct
Background A variety of small mobile phone text-
messaging interventions have indicated improvement in 
risk factors for cardiovascular disease (CVD). Yet the extent 
of this improvement and whether it impacts multiple 
risk factors together is uncertain. We aimed to conduct 
a systematic review and individual patient data (IPD) 
meta-analysis to investigate the effects of text-messaging 
interventions for CVD prevention.
Methods Electronic databases were searched to identify 
trials investigating a text-messaging intervention focusing 
on CVD prevention with the potential to modify at least 
two CVD risk factors in adults. The main outcome was 
blood pressure (BP). We conducted standard and IPD 
meta-analysis on pooled data. We accounted for clustering 
of patients within studies and the primary analysis used 
random-effects models. Sensitivity and subgroup analyses 
were performed.
Results Nine trials were included in the systematic 
review involving 3779 participants and 5 (n=2612) 
contributed data to the IPD meta-analysis. Standard meta-
analysis showed that the weighted mean differences are 
as follows: systolic blood pressure (SBP), −4.13 mm Hg 
(95% CI −11.07 to 2.81, p<0.0001); diastolic blood 
pressure (DBP), −1.11 mm Hg (−1.91 to −0.31, p=0.002); 
and body mass index (BMI), −0.32 (−0.49 to −0.16, 
p=0.000). In the IPD meta-analysis, the mean difference 
are as follows: SBP, −1.3 mm Hg (−5.4 to 2.7, p=0.5236); 
DBP, −0.8 mm Hg (−2.5 to 1.0, p=0.3912); and BMI, −0.2 
(−0.8 to 0.4, p=0.5200) in the random-effects model. The 
impact on other risk factors is described, but there were 
insufficient data to conduct meta-analyses.
Conclusion Mobile phone text-messaging interventions 
have modest impacts on BP and BMI. Simultaneous but 
small impacts on multiple risk factors are likely to be 
clinically relevant and improve outcome, but there are 
currently insufficient data in pooled analyses to examine 
the extent to which simultaneous reduction in multiple risk 
factors occurs.
PROSPERO registration number CRD42016033236.
IntROduCtIOn
Globally, deaths due to cardiovascular disease 
(CVD) have steadily increased over the last 
four decades,1 with ischaemic heart diseases 
remaining as the single largest cause of death.2 
A large body of evidence has demonstrated 
that common and modifiable risk factors, 
including high blood pressure (BP), smoking, 
high cholesterol, obesity and physical inactivity, 
contribute substantially to the risk of CVD 
and premature death.3–8 However, identifying 
low-cost, scalable and effective strategies to 
target all of these to prevent CVD and recur-
rent CVD events remains a major challenge.
In recent years, mobile health (mHealth) 
programmes have emerged as a strategy to 
support chronic health conditions. Much of 
the fervour around mHealth has been because 
of the potential seen to reduce socioeconomic 
disparity and to deliver a scalable low-cost 
intervention to a wide population and thus 
Key questions
What is already known about this subject?
 ► A variety of small mobile phone text-messaging in-
terventions have indicated improvement in risk fac-
tors for cardiovascular disease (CVD).
What does this study add?
 ► This is the first individual patient data meta-analysis 
showing the impact of text messaging on secondary 
prevention of CVD.
How might this impact on clinical practice?
 ► Text messaging is acceptable, generalisable and 
scalable and has modest impacts on multiple CVD 
risk factors with public health significance.
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alleviate the burden of CVD.9 Two systematic reviews on 
mHealth interventions for secondary prevention of CVD 
reported that mHealth offers potential for improving CVD 
secondary prevention.10 11 The 2018 review7 included 9 
(n=3637) studies using text messaging, and the 2016 study8 
included 28 studies (n=3820) using mHealth technologies 
(including text messaging, mobile apps and internet); 
neither of the reviews performed meta-analysis. The 
majority of studies showed the effectiveness of mHealth 
and text messaging in improving behaviours, patient satis-
faction and clinical outcomes in patients with CVD. Text 
messaging and apps showed the highest user adherence 
and satisfaction compared with internet or continuous 
monitoring. The 2018 review concluded that text messaging 
might be a useful tool for secondary prevention of CVD, but 
conclusions were largely based on qualitative assessment of 
studies, and the 2016 review concluded that mobile phone 
features such as text messaging and apps have a strong 
potential to positively impact the secondary prevention 
of CVD. They suggested further research was needed to 
apply rigorous research designs with theory-based inter-
ventions, to measure economic benefits, process evaluation 
and adverse effects of the intervention, and were unable to 
address the frequency and content of text messaging and 
long-term impacts of the intervention on clinical outcomes 
and end points.
The global reach and ubiquity of mHealth interven-
tions suggest they may be useful, but despite almost a 
decade of research, the evidence base remains limited. 
In this context, we performed a systematic review and 
meta-analysis of randomised controlled trials (RCTs) of 
text-messaging interventions used for the prevention 
of CVD risk factors to generate robust evidence and to 
identify researchers active in this field. We established 
the Text2PreventCVD Trial Collaborators Group, a 
global network of researchers working on mHealth inter-
ventions in CVD prevention and management, with the 
goals of collaboration to facilitate the next generation 
of trials. In the current paper, the Text2PreventCVD 
Collaboration aimed to quantify the extent of improve-
ment in cardiovascular risk factors with mobile phone 
text-messaging interventions using systematic review and 
individual participant data (IPD) meta-analysis. Studies 
included needed to involve interventions that had the 
potential to impact on at least two measures of cardiovas-
cular risk factors. The primary outcome designated for 
these analyses was systolic blood pressure (SBP) and the 
secondary outcomes included diastolic blood pressure 
(DBP) and body mass index (BMI).
MEtHOdS
We performed a systematic review and IPD meta-analysis 
and reported in accordance with the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses state-
ment and the Cochrane Collaboration reporting items 
for systematic reviews and meta-analysis guidelines.12 
This review is registered in the International Prospective 
Register of Systematic Reviews. The study protocol has 
been published previously.13
Search strategy
We searched MEDLINE, Embase, PsycINFO (Ovid) and 
the Cochrane Central Register of Controlled Trials for 
reports published from 1 January 1990 to 1 July 2016 to 
identify RCTs of text-messaging interventions used for 
the prevention of CVD risk factors. The following Medical 
Subject Headings search terms were used: (1) interven-
tion (text messaging, text messages, short message service 
(SMS), text message mobile phone, cellular phone, 
texting, SMS); (2) CVD (heart disease, coronary disease, 
BP, hypertension, lipids, cholesterol, cardiovascular risk 
factors, myocardial infarction, vascular, diabetes and 
obesity) and (3) study design (RCT). We also searched 
for ongoing, recently completed and unpublished clin-
ical trials meeting the inclusion criteria described earlier 
from different trial registers and reference lists of selected 
studies, and reviewed grey literature for any other rele-
vant studies. Consultation and contacts with experts in 
the field were made to help identify relevant studies.
Study eligibility
Full details of the methods used have been reported previ-
ously.13 In brief, studies were eligible if they were RCTs of 
a text-messaging intervention focused on CVD preven-
tion (primary or secondary) with at least two behaviour 
change strategies, for example, physical activity and diet 
or BP lowering, smoking and cholesterol lowering14; 
study duration was at least 6 months and 70% completed 
the follow-up of participants; study participants were 
adults, the sample size was larger than 30 people, and the 
control group received standard care. Reports published 
in any language were considered.
Study selection and data extraction
Two researchers (SMSI and KS) independently screened 
titles and abstracts to identify studies meeting the inclu-
sion criteria described previously. One researcher (SMSI) 
extracted and tabulated all relevant data in a predefined 
data extraction sheet and a second researcher (KS) 
checked it for accuracy. Extracted data included patient’s 
baseline characteristics; the type and duration of the inter-
vention; changes in SBP and DBP, BMI, weight and lipids; 
and any possible adverse outcome reported. Disagreement 
was resolved by consensus or in consultation with a third 
reviewer (CKC). Corresponding authors of the selected 
studies were invited to join the Text2PreventCVD Collabo-
ration and to contribute data to the IPD meta-analysis.
Outcomes
The primary outcome was the difference between inter-
vention and control groups in SBP at 6 months. However, 
as two studies15 16 did not have complete SBP data at 6 
months’ follow-up, we performed the analysis based on 
end of follow-up data. We also sought to examine other 
measures of cardiovascular risk, including low-density 
lipoprotein (LDL) cholesterol, smoking, diet, quality of 
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Meta-analysis
Figure 1 Study selection process. CENTRAL, Cochrane 
Central Register of Controlled Trials. CVD, cardiovascular 
disease; IPD, individual patient data; SMS, short message 
service.
life and physical activity. However, due to insufficient data 
availability, we were only able to conduct meta-analysis to 
analyse diastolic BP and BMI as secondary outcomes at 
the end of the follow-up period.
Assessment of study quality
Study quality was assessed using the Cochrane collabo-
ration risk of bias assessment tool,17 based on random 
sequence generation, allocation concealment, blinding 
of participants and personnel, blinding of outcome 
assessment, incomplete outcome data, selective reporting 
and other bias.
Statistical analysis
Analyses were conducted in accordance with contem-
porary recommendations for IPD meta-analyses.18–21 
Primary and secondary outcome analyses were performed 
on the combined dataset using preferred one-stage 
IPD meta-analyses (ie, individual patient data (IPD) 
were pooled and then models run on the combined 
dataset).20 22 The primary analyses consisted of a linear 
mixed model with the end-of-trial value as the outcome, 
the baseline value and the treatment arm as random 
effects, and a random trial intercept and random trial-by-
treatment interaction. An interim meta-analysis (standard 
meta-analysis) of the systematic review was performed 
using both fixed and random-effects models to compare 
the results with the IPD meta-analysis. Sensitivity anal-
yses included two-stage approaches using both random 
and fixed-effects meta-analyses, analysis of 6-month 
follow-up values as the outcome and excluding data from 
the heart exercise and remote technologies (HEART) 
study, which measured BP in the context of participants 
doing exercise. Subgroup analyses were performed using 
the one-stage IPD and fitting a subgroup and subgroup 
by treatment interaction fixed effect into the model so 
heterogeneity between subgroup categories (education, 
age and gender) could be assessed. All data analyses were 
carried out using STATA V.12 and SAS V.9.2.
RESultS
Study characteristics
Out of a total of 1210 identified citations, nine trials 
consisting of 3779 participants met the inclusion criteria 
of our systematic search (figure 1). We contacted all 
nine study groups and five agreed to contribute data 
to the IPD meta-analysis described further. Characteris-
tics of the nine trials are shown in table 1. The median 
sample size was 236 (range 123–1372) and the median 
intervention period was 6 months (range 6–24 months). 
The mean age of the participants was 54.1±5.5 years 
and 37.5% were women. The gender spread across the 
studies was broad from one study of 100% men23 to one 
with <30%.15 The trials included participants with a range 
of levels of absolute cardiovascular risk from primary 
prevention to secondary prevention populations. Of the 
nine trials included, one trial included ‘normal’ partic-
ipants not on drug therapy,23 with the others including 
patient populations selected on the basis of having a 
cardiovascular risk factor or CVD; for example, two 
studies included participants with high BP,15 16 three 
with coronary heart diseases,24–26 two with diabetes,27 28 
one included only working men with no diabetes23 and 
one participant taking medication for either BP or lipid 
lowering.29 Five studies recruited participants from 
hospital settings,16 24–26 28 two from primary healthcare 
settings,15 29 one from a hospital emergency department27 
and one in an industrial area work setting.23 The dura-
tion of the text-messaging intervention was 6 months for 
seven studies,24–29 12 months for one15 and 24 months for 
another.23
text message intervention characteristics
There was considerable variation in the characteristics 
of the individual text-message interventions (see online 
supplementary table S1). Five studies provided text 
messages as a stand-alone intervention. Four studies 
provided additional support to participants in the form of 
telephone support16 29 and via secure website.25 26 Message 
frequency varied from one message per week up to two 
messages per day. Four studies sent text messages at a 
fixed predetermined frequency.24 27–29 Most studies used 
unidirectional text messaging and three used interactive 
text messaging.15 25 29 Six studies used personalised or 
semipersonalised text messages, while three studies used 
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Meta-analysis
Figure 2 Standard meta-analysis at end follow-up on systolic blood pressure results (random-effects model). MPID, mobile 
phone intervention for diabetes; WMD, weighted mean difference.
generalised messages.16 27 28 Message content was based 
on clinical guidelines (five studies), expert opinion (two 
studies) and feedback from formative qualitative work 
(three studies). The number of behaviour change strat-
egies used ranged from 2 to 17. Seven studies reported 
patient feedback on the text messaging.16 23–29
Standard meta-analysis of the intervention efficacy
Of the 3779 participants, 295 did not have complete data 
and were excluded from the analysis. In the pooled anal-
ysis of 3348 patients, using a random-effects model, text 
message intervention significantly reduced SBP at the 
end of follow-up (weighted mean difference −4.13 mm Hg 
(95% CI −11.07 to −2.81, p=<0.0001) (figure 2). There 
was high heterogeneity (I2 97.3%) across the clinical trials 
due to one study with a large effect size.16 The weighted 
mean difference in DBP was −1.11 mm Hg (95% CI −1.91 
to −0.31, p=0.002, I2 77.2%) and BMI was −0.32 (95% CI 
−0.49 to −0.158, <0.0001, I2 91.5%).
IPd meta-analysis of the intervention efficacy
The IPD meta-analysis involved five studies with 1976 partic-
ipants from Australia, Bangladesh, New Zealand and South 
Africa (table 2). The mean difference in SBP at the end 
of the follow-up period was −1.3 mm Hg (95% CI −5.4 to 
2.7, p=0.5236, I2 89.0%) in the random-effects model. The 
mean differences in DBP and BMI were −0.8 mm Hg (95% 
CI −2.5 to 1.0, p=0.3912, I2 77.2%) and −0.2 mm Hg (95% 
CI −0.8 to 0.4, p=0.5200, I2 91.5%), respectively, at the end 
of the follow-up using the random-effects model (table 3).
Other CVd risk factors
Three studies25 27 28 included in the standard meta-analysis 
reported effects of text messaging on medication adher-
ence using Morisky’s eight-item medication adherence 
scale (MMAS-8).30 These studies showed improvement 
in the MMAS-8 score to a varying degree 1.1 (95% CI 0.1 
to 2.1), −0.11 (95% CI −0.49 to 0.26) and 0.58 (95% CI 
0.19 to 0.97). Three studies measured changes in LDL 
cholesterol, but data were presented in reports for only 
two studies −0.11 mg/dL (95% CI −0.49 to 0.26, p=0.04)24 
and −0.25 mg/dL (95% CI −0.49 to 0.01, p=0.053).25 Two 
studies reported changes in glycated haemoglobin with a 
mean difference of −0.45% (p=0.230)27 and −0.64% (−0.95 
to −0.33).28
With respect to whether interventions impacted on 
multiple cardiovascular risk factors, four studies15 23 24 28 
showed statistically significant reductions in two or more 
cardiovascular risk factors, while two studies27 31reported 
improvements (not statistically significant) in two or 
more cardiovascular risk factors at the end of the study 
(see online supplementary table S5). One study reported 
concurrent reductions in LDL cholesterol, BP, BMI, phys-
ical activity and smoking, with 28.9% achieving at least four 
guideline levels of cardiovascular risk factors in the inter-
vention group, compared with 10.3% in the control group 
and 4.7% achieving all five guideline levels in the interven-
tion group, compared with 1.8% in the control group.24
Sensitivity analysis
A sensitivity analysis was conducted in which data from 
the HEART trial26 were excluded, mainly because BP 
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ue
d
was measured in the context of cardiopulmonary exer-
cise testing. As a result, reductions were found for SBP 
−3.7 mm Hg (95% CI −5.1 to −2.3), DBP −1.6 mm Hg 
(95% CI −2.5 to −0.7) and BMI −0.5 (95% CI −0.7 to −0.3) 
(see online supplementary table S2).
Effects stratified by subgroup analysis
To further assess the impact of text messages, we 
performed an analysis based on participant characteris-
tics. The moderators assessed were education (<12 years 
vs ≥12 years), age (<60 years vs ≥60 year) and gender 
(male vs female). There was no significant variation in 
the effectiveness of text message intervention by strata 
(see online supplementary table S3).
Study quality
We assessed the study quality as per Cochrane guide-
lines12 (see online supplementary table S4). All studies 
described a randomisation sequence generation tech-
nique that was at low risk of bias except one that had 
an unclear risk of bias.16 Three studies did not report 
allocation concealment and were categorised as unclear 
allocation concealment.16 23 27 Blinding of study partici-
pants was not possible due to the nature of intervention 
for any of the studies. Blinding of outcome assessments 
was not clearly described in four studies.16 25 27 29 Six 
studies were reported to have low incomplete outcome 
data,15 23–27 29 one with unclear outcome data28 and one 
with high incomplete outcome data.16 All studies scored 
low in selective reporting and other bias, while only one 
study had unclear other bias.16 Overall, 7 (78 %) studies 
were thought to be of high quality with a maximum of 
one unclear assessment.15 23–26 28 29 Publication bias could 
not be assessed as the number of trials was few.
text message acceptability
Participant feedback on text-message acceptability was 
reported in seven studies16 23–28 (see online supplemen-
tary table S2). Most studies reported moderate to high 
levels of satisfaction with the text-messaging programme. 
Participants acknowledged text-message support as a 
useful and expressed desire to programme continuation. 
In one study,28 32 participants were willing to pay a small 
fee to receive the text-messaging programme. In one 
study, a small fraction (3%) of the participants felt that 
the messages were disturbing.23
dISCuSSIOn
The main findings of this paper is that mobile phone 
text-messaging interventions have modest impacts on 
objective measures of cardiovascular risk factors of BP 
and BMI in analyses of pooled data using standard and 
IPD meta-analyses. Modest impacts on cardiovascular risk 
factors could have clinical and/or public health signifi-
cance if they could impact on multiple risk factors simul-
taneously and/or do this at a very low cost, but the current 
data are not conclusive on these points. The pooled data 
are from a number of different regions, and the high 
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Table 3 Individual patient data meta-analysis at the end of follow-up*
Outcome Model Intervention Control
Mean difference
(95% CI)
P value for the 
difference
SBP Random-effects model (1a) 132.1 (128.7 to 135.5) 133.4 (130.0 to 136.8) −1.3 (−5.4 to 2.7) 0.5236
Fixed-effects model (2) 131.3 (130.2 to 132.4) 134.3 (133.2 to 135.4) −3.1 (−4.4 to −1.7) <0.0001
DBP Random-effects model (1a) 80.9 (79.4 to 82.4) 81.7 (80.2 to 83.2) −0.8 (−2.5 to 1.0) 0.3912
Fixed-effects model (2) 80.6 (79.8 to 81.3) 81.9 (81.2 to 82.6) −1.3 (−2.2 to −0.5) 0.0018
BMI Random-effects model (1b) 30.6 (30.2 to 31.1) 30.8 (30.4 to 31.3) −0.2 (−0.8 to 0.4) 0.5200
Fixed-effects model (2) 30.5 (30.3 to 30.7) 31.0 (30.8 to 31.1) −0.5 (−0.7 to −0.3) <0.0001
Note: All randomised patients with both visits assessed at baseline and at month 6 have been included in this analysis.
Primary analysis—analysis of covariance, including randomised treatment and baseline value as fixed effect: model 1: (a) includes trial 
random effect and random treatment by trial interaction, (b) includes trial fixed effect and random treatment by trial interaction when model 
1a estimates trial random effect to zero; model 2: only fixed effects, including trial effect; model 3: sensitivity analysis pooling the estimates 
from the five trials using a standard meta-analysis checking for data heterogeneity between trials.
*For the StAR study, 12 month data was used for follow-up. For all other studies, 6 month data was used for follow-up.
BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
acceptability of texting interventions reported by most 
studies in our review suggests generalisability of findings 
and potential for widespread implementation, but there 
is still relatively few large-scale or multicentre evaluations.
Efficient, simultaneous risk factor reduction is 
important in the prevention of CVD as risk reduction 
is additive across single risk factors; for example, BP 
lowering plus lipid lowering is more effective at reducing 
risk than either alone. The reasons that the data are still 
inconclusive are likely because of the small number of 
individual participants in trials, the heterogeneity of 
the study population (including primary and secondary 
prevention populations), the heterogeneity of the inter-
ventions and the likely small individual impact of the 
interventions themselves.
Mobile phone text messaging might be a low-cost inter-
vention, but data on cost-effectiveness are still limited. One 
of the studies included had a published cost-effectiveness 
study that modelled implementation of the text-message 
intervention to a target population of 50 000 patients with 
coronary heart disease; the intervention was estimated to 
lead to 563 fewer myocardial infarctions, 361 fewer strokes 
and 1143 additional quality adjusted life years, and was asso-
ciated with an overall saving of $10.56 million for the health 
system over the patients’ lifetimes.33
There have been some previous systematic reviews in 
mHealth interventions for CVD secondary prevention. One 
recent systematic review of mobile phone interventions for 
secondary prevention of CVD reported that text messaging 
was effective in improving clinical outcomes better than 
smartphone-based interventions.11 The study discussed 
that incorporating principles of behavioural change may 
help promote and sustain healthy lifestyle behaviours in 
patients with CVD, resulting in better outcomes.11 Another 
systematic review of mobile phone text messaging for 
improving secondary prevention in CVD suggested that 
text messaging might be beneficial for secondary preven-
tion of CVD but failed to draw reliable conclusions.10 A 
2017 systematic review identified six studies using text 
messaging for hypertension management but did not 
perform meta-analysis due to variation in the studies.34 The 
study concluded that text messaging had strong potential 
for innovation in hypertension management, especially in 
minority groups and those with low access to healthcare 
services. All these systematic reviews suggested that text 
messaging might have a role in secondary prevention of 
CVD but could not quantify effectiveness due to a lack of 
meta-analysis. Our study is therefore unique as it used IPD 
as well as meta-analysis.
The main mechanism by which texting intervention 
appear to work is via behavioural change. All trials included 
in our review incorporated two or more behaviour change 
theories. Behaviour change interventions and techniques, 
including motivational interviewing,35 increasing patient 
motivation and self-efficacy,36 goal setting combined with 
self-monitoring of behaviour,37 supporting medical adher-
ence and multimodal behavioural interventions, have 
been highlighted as effective in various CVD prevention 
programmes.38 39 Text messaging offers confidential and 
unobtrusive support, which is an advantage over other 
interventions.
Strengths and limitations
The primary limitation of this meta-analysis was the 
differences in participants’ characteristics, risk factor 
measurements and primary outcomes of interest across 
studies. A potential limitation is the small number of 
trials and a highly significant study included in the 
meta-analysis,16 potential publication bias and influence 
of heterogeneity is possible. Of the nine trials included 
in the standard meta-analysis, we were only able to 
obtain full datasets from five trials. Also, we calculated 
the effect estimate from available data from published 
studies, and it is thus possible that bias can be intro-
duced from differential loss to follow-up. Therefore, 
the results of this IPD meta-analysis cannot be general-
ised across different populations and should be inter-
preted with caution. Finally, the meta-analysis is not a 
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mechanistic study; thus, we cannot determine whether 
the benefit associated with the use of text messaging 
was attributable to BP lowering or to other mechanisms.
The primary strength of this meta-analysis was its 
systematic search to identify potential studies and the 
inclusion of only RCTs, which are less subject to bias 
and confounding than observational studies. The IPD 
analysis approach used in this study has advantages over 
a meta-analysis because the outcomes can be matched 
between studies and all studies are then analysed in the 
same prespecified statistical model. The use of data from 
many studies with different inclusion criteria should 
make the findings more generalisable, and the robust-
ness of the main conclusions to subsidiary methods of 
analysis further supports the conclusion drawn.
Future research
There are still a number of unanswered questions that we 
were unable to adequately address, for example, whether 
different characteristics of the texting interventions influ-
enced outcomes (ie, number of behaviour change tech-
niques used, unidirectional vs bidirectional, high vs low 
frequency, personalised vs non-personalised). How can 
effects be maintained into the longer term and how are 
interventions best scaled up to populations? Future studies 
should address these questions, as well as the potential of 
these interventions in varied socioeconomic groups, age 
groups and cultures. Variations in effectiveness of behav-
ioural interventions have been shown by gender.37 40
In addition, substantial variability exists with regard to the 
definitions of outcome measures for the different cardio-
vascular risk factors across studies. A standardised method 
for measuring the different outcomes in CVD prevention is 
warranted to improve comparability of outcome measures 
across studies for a more rigorous and reliable evaluation of 
the effectiveness of mHealth interventions for CVD.
COnCluSIOn
Mobile phone text-messaging interventions have modest 
impacts on objective measures of BP and BMI. Evidence 
is suggestive, but inconclusive, that texting is acceptable, 
generalisable and scalable, and their modest impacts on 
cardiovascular risk factors may apply to multiple cardio-
vascular risk factors and hence make this a mHealth solu-
tion with public health significance.
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